Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
11m agoFatPipe Unveils VeloCloud Replacement Program with Price Match, 15% Discounts and 10% Partner Rebates
37m agoAngle Advisors announces Shift Transit has been recapitalized by Main Street Capital Corporation
37m agoCentury Complete Announces New Homes Coming Soon to Fleming Island, FL
38m agoSprott Physical Copper Trust Announces Preliminary Proxy Results for Unitholder Meeting and Anticipated Listing Date on the NYSE Arca
39m agoTambourine & Hyatt Launch Hyatt Wedding Guide to Revolutionize Digital Wedding Planning
Exelixis Inc logo

Exelixis Inc

About

Exelixis Inc (NASDAQ:EXEL) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 21 2026
Exelixis to Release First Quarter 2026 Financial Results on Tuesday, May 5, 2026
Feb 24 2026
Exelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in March
Feb 10 2026
Exelixis Announces Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Corporate Update
Feb 2 2026
Exelixis Announces U.S. FDA Accepted the New Drug Application for Zanzalintinib in Combination with an Immune Checkpoint Inhibitor for Patients with Metastatic Colorectal Cancer
Jan 27 2026
Exelixis to Release Fourth Quarter and Fiscal Year 2025 Financial Results on Tuesday, February 10, 2026

Financials

Revenue
$2.32 B
Market Cap
$11.76 B
P/E Ratio
15.78
EPS
2.78

Community Chat

Ask AI

6ix6ixAIEvents